Simple sleep strategy maps out daily habits to improve rest, metabolism and weight Registered dietitian Erin Palinski-Wade, author of "The Sleepdemic Solution," reveals how meal timing, natural light exposure and nighttime routines can help support healthier circadian patterns.
Popular weight-loss drugs may help protect against a deadly disease, doctor says A breast cancer surgeon explains how GLP-1 drugs like Ozempic and Wegovy may lower cancer recurrence risk by reducing BMI, estrogen and inflammation.
Jillian Michaels exposes dangers of self-dosing illegal 'gray market' weight loss drugs Fitness expert Jillian Michaels warns Americans against self-dosing "gray market" weight-loss peptides, citing health risks like vision loss and hormonal damage.
Weight-loss joke turns serious as 'cyclospora skinny' trend fuels health warnings A dangerous social media trend jokes about getting "Cyclospora skinny," but doctors warn the intestinal parasite causes deadly dehydration and illness.
Skipping sleep may pack on pounds faster than you think, new study finds A Columbia University study found that losing just 90 minutes of sleep per night led to weight gain and larger waistlines in adults over six weeks.
Weight loss drugs may improve job prospects and dating odds for one group A weight loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders Neurologists warn that GLP-1 weight-loss drugs like semaglutide may accelerate ALS progression by triggering dangerous rapid weight loss in patients.
Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health Dr. Mehmet Oz backs GLP-1 weight loss medication but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.
Dr Oz says weight-loss shots may help tackle America’s chronic illness crisis CMS administrator Dr. Mehmet Oz discusses the role of GLP-1 medications in combating obesity, saying they can support better health when combined with lifestyle changes and medical guidance.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'